Back to Dividend Stocks
 NeoGenomics Inc. (NEO) logo

NeoGenomics Inc.

S&P 500

NEO/Healthcare · Diagnostics & Research/NASDAQ

Stock Price

$13.73

Stock Price$13.73MCap1.5BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

NEO does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About NeoGenomics Inc.

NeoGenomics Inc. is a leading cancer diagnostics company specializing in oncology genetics testing and information services. It offers one of the most comprehensive menus of oncology-focused tests worldwide, including next-generation sequencing (NGS), comprehensive genomic profiling, and advanced assays like RaDaR ST for molecular residual disease (MRD) detection in solid tumors and PanTracer Pro for integrated diagnostics in advanced-stage cancers. The company provides clinical cancer testing, professional interpretation by pathologists and molecular experts, clinical trials support, research services, validation laboratory services, and oncology data solutions to pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, and managed care organizations across the United States and Europe. NeoGenomics operates a network of CAP-accredited and CLIA-certified laboratories in multiple U.S. locations and the United Kingdom, with its Pharma Services Division supporting drug development for pharmaceutical clients. Founded in 1998 and headquartered in Fort Myers, Florida, NeoGenomics plays a key role in precision oncology by enabling personalized cancer diagnosis and treatment.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$4.72 - $13.88

Earnings & Profitability

NEO earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

NEO Dividend Calculator

Total Investment

$1,373.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is NEO's current dividend yield?
NeoGenomics Inc. (NEO) currently has a dividend yield of 0.00%, based on a stock price of $13.73 and an annual dividend of $0.00.
When is NEO's next dividend payment date?
NEO's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does NEO pay in dividends per year?
NeoGenomics Inc. pays dividends unknown. Annual dividend data is not yet available.
Has NEO been increasing its dividend?
NeoGenomics Inc. has grown its dividend at a 5-year CAGR of —.
Is NEO's dividend safe?
NeoGenomics Inc. has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.
How is NEO's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates NeoGenomics Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track NEO Dividends with OnlyDividends

What will NEO actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

Download the App

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.